Top Healthcare Stocks
Healthcare stocks are higher this afternoon, with the NYSE
Healthcare Sector Index adding 0.4% and shares of healthcare
companies in the S&P 500 rising 0.6% as a group.
In company news, Regulus Therapeutics (
) is holding a 4.7% advance, with shares adding 28 cents to reach
$6.18 this afternoon after the drug-maker reported a Q3 net loss of
$0.07 per share, half the $0.14 per share loss that analysts, on
average, were expecting.
Revenue rose 118% year over year to $6.1 million, also crushing
Street expectations by $2.7 million.
RGLS also is picking up support after saying it expects to soon
file the regulatory applications for its RG-101 drug candidate,
with clinical studies in human patients for the prospective
hepatitis C treatment expected to begin early next year.
In other sector news,
(+) CGIX, (+10.8%) Narrows Q3 net loss to $0.61 per share
compared with a $2.23 loss in the year-ago period. Revenue climbs
37% year over to $1.7 mln while test volumes jump 71% to 2920
diagnostic procedures during the quarter.
(-) THRX, (-0.4%) Tables Phase II testing of its TD-9855 drug
candidate after the prospective treatment for
Attention-Deficit/Hyperactivity Disorder in adult patients failed
to reduce symptoms. Testing in patients with fibromyalgia will
Copyright (C) 2013 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.